Wells Fargo raised the firm’s price target on Delek US (DK) to $53 from $43 and keeps an Overweight rating on the shares. The firm says the company quantified SRE benefits and offered a SoP valuation. Even without full credit for EPO, Wells sees ongoing upside to shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK: